Age: 66.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Bradykinesia, Malaise, Multiple allergies
Clinical narrative: she was not feeling well today; she was moving slow; she had allergies; This is a spontaneous report from a Pfizer-sponsored program XELSOURCE. A contactable consumer (patient) reported that a 66-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number, Expiry date, NDC number: Unknown), via an unspecified route of administration, administered in left arm on 10Apr2021 (age at vaccination was 66 years) as dose 2, single for COVID-19 immunisation at pharmacy. tofacitinib citrate (XELJANZ XR, Prolonged-release tablet, Batch/Lot Number: ED3279, Expiry date: 11Dec2022), via an unspecified route of administration from an unspecified date and ongoing, at 11 mg, once a day for an unspecified indication. The patient had been taking Xeljanz XR for a few years. Medical history includes seasonal allergies, patient clarified she had seasonal allergies for a long time, and her seasonal allergies were bad in the spring and fall. Concomitant medications were not reported. Historical vaccine includes the fist dose of BNT162B2 in left arm on 13Mar2021 for COVID-19 immunisation and experienced headache. The patient said she took one Aleve, and the headache went away. She said she did not have the Aleve bottle to provide the Aleve dosing, NDC, Lot, and Expiration Date. The patient previously took methotrexate, reported patient was first on Methotrexate 2.5mg, and the Methotrexate totally wrecked her. She said her sodium levels went down, and she was told not to drink water because she didn't have enough salt. She said her sodium level went crazy. She stated she did not remember when she stopped taking the Methotrexate 2.5mg, but she had a prescription bottle from 2018. She said the Methotrexate 2.5mg was dispensed in a pharmacy bottle, and she did not have a NDC, Lot, and Expiration Date. The patient previously took hydroxychloroquine and experienced visual impairment, reported she was on Hydroxychloroquine (or Plaquenil) in the past, and she had to get off of the Hydroxychloroquine because it was effecting her vision. She said she did not know the Hydroxychloroquine dose, but she took the Hydroxychloroquine twice a day. She said she stopped the Hydroxychloroquine several months ago. She said the Hydroxychloroquine was dispensed in a pharmacy bottle, and she did not have the NDC, Lot, and Expiration Date.  On 22Apr2021, the patient was experienced she was not feeling well today and she was moving slow, on an unspecified date she had allergies. Additional context reported as, Reported she had both of her Pfizer COVID-19 Vaccine shots. She clarified she had her first COVID-19 Vaccine shot on 13Mar2021 and her second COVID-19 Vaccine on 10Apr2021. She said she had both COVID-19 Vaccine shots in her left arm. She said her COVID-19 Vaccination card did not have a Pfizer NDC, Lot, and Expiration Date listed. She said the only number listed on her vaccination card was PAA163969 for both COVID-19 Vaccine doses. a patient who takes Xeljanz XR 11mg, and stated she was not feeling well today (22Apr2021) and was moving slow. The transferring agent said the patient stated there was pollen where she was and she had allergies. The transferring agent said she assisted the patient with getting a Xeljanz XR 11mg refill. Reported the pollen was extreme where she was, and she had allergies. She clarified she had seasonal allergies for a long time, and her seasonal allergies were bad in the spring and fall. No investigation assessment reported. Outcome of the event multiple allergies was unknown and for remaining events outcome was not resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained